Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
暂无分享,去创建一个
Sylvain Houle | Alan A. Wilson | Nathalie Ginovart | S. Houle | N. Ginovart | D. Hussey | J. Kennedy | Jeffrey H Meyer | Alan A Wilson | James Kennedy | Sandra Sagrati | Anna Carella | Doug F Hussey | Verdell Goulding | Verdell S. Goulding | J. Meyer | V. Goulding | S. Sagrati | A. Carella | J. Meyer | J. Kennedy
[1] Richard E Carson,et al. Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] Sylvain Houle,et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. , 2003, The American journal of psychiatry.
[3] J. Oliver,et al. The Dysfunctional Attitude Scale: Psychometric properties and relation to depression in an unselected adult population , 1985, Cognitive Therapy and Research.
[4] J. Palacios,et al. Autoradiography of antidepressant binding sites in the human brain: localization using [3h]imipramine and [3h]paroxetine , 1988, Neuroscience.
[5] Alexander Neumeister,et al. [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder , 2000, Biological Psychiatry.
[6] A. Rush,et al. Cognitive biases and depression. , 1989, Journal of abnormal psychology.
[7] B. McEwen,et al. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.
[8] R. Pihl,et al. Tryptophan depletion causes a rapid lowering of mood in normal males , 2004, Psychopharmacology.
[9] Alan A. Wilson,et al. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. , 2001, The American journal of psychiatry.
[10] C. Katona,et al. Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides , 1990, Brain Research.
[11] J. Marcusson,et al. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue , 1989, Brain Research.
[12] B. Jacobs,et al. Structure and function of the brain serotonin system. , 1992, Physiological reviews.
[13] I. Ferrier,et al. 5HT2 receptor changes in major depression , 1990, Biological Psychiatry.
[14] V. Arango,et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.
[15] A. Simons,et al. The process of change in cognitive therapy and pharmacotherapy for depression. Changes in mood and cognition. , 1984, Archives of general psychiatry.
[16] E. Leibenluft,et al. Dysfunctional Attitudes in Borderline Personality Disorder , 1991 .
[17] Jeih-San Liow,et al. Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] D. Chuang,et al. Characterization of Two [3H]Ketanserin Recognition Sites in Rat Striatum , 1987, Journal of neurochemistry.
[19] A. Beck,et al. Prediction of eventual suicide in psychiatric inpatients by clinical ratings of hopelessness. , 1989, Journal of consulting and clinical psychology.
[20] Stanley J. Watson,et al. Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide , 1997, Biological Psychiatry.
[21] Hinako Toyama,et al. Quantitative Analysis for Estimating Binding Potential of the Brain Serotonin Transporter with [11C]McN5652 , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] G. Aghajanian,et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.
[23] Alan A. Wilson,et al. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. , 2001, The American journal of psychiatry.
[24] A. Beck,et al. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. , 1985, The American journal of psychiatry.
[25] M. Åsberg,et al. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.
[26] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[27] E. Perry,et al. Decreased Imipramine Binding in the Brains of Patients with Depressive Illness , 1983, British Journal of Psychiatry.
[28] V. Arango,et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.
[29] M. Alda,et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. , 1999, The American journal of psychiatry.
[30] M. Fava,et al. Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression. , 1999, Journal of affective disorders.
[31] I. Miller,et al. Characteristics of depressed patients with elevated levels of dysfunctional cognitions , 1988, Cognitive Therapy and Research.
[32] F. Yasuno,et al. Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652 , 2002, Biological Psychiatry.
[33] M. Kuhar,et al. Cocaine and 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. , 1995, Journal of medicinal chemistry.
[34] Marc Laruelle,et al. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites , 1988, Biological Psychiatry.
[35] M Slifstein,et al. In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] S. Houle,et al. Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of (11)C-Labeled 2-(Phenylthio)araalkylamines. , 2000, Journal of medicinal chemistry.
[37] P A Sargent,et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.
[38] A. Andrews,et al. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression , 2004, Journal of Neuroscience Methods.
[39] F. Artigas,et al. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. , 1992, European journal of pharmacology.
[40] M. Blais,et al. A psychometric evaluation of the DSM-IV personality disorder criteria. , 1997, Journal of personality disorders.
[41] Linda Carpenter,et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography , 1998, Biological Psychiatry.
[42] Masanori Ichise,et al. Modeling of Receptor Ligand Data in PET and SPECT Imaging: A Review of Major Approaches , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[43] A. Greenshaw,et al. A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition , 2004, Psychopharmacology.
[44] B. Mulsant,et al. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. , 1999, The American journal of psychiatry.
[45] C Burger,et al. Requirements and implementation of a flexible kinetic modeling tool. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[46] C. Stockmeier,et al. In vivo regulation of the serotonin-2 receptor in rat brain. , 1986, Life sciences.
[47] D. Murphy,et al. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. , 1984, Life sciences.
[48] Sylvain Houle,et al. In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. , 2002, Nuclear medicine and biology.
[49] Alan A. Wilson,et al. Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[50] M. Raichle,et al. Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.
[51] Alan A. Wilson,et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.
[52] Sylvain Houle,et al. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. , 2004, The American journal of psychiatry.
[53] T. Crow,et al. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides , 1984, Neuropharmacology.
[54] Sylvain Houle,et al. Lower dopamine transporter binding potential in striatum during depression , 2001, Neuroreport.
[55] A. Beck,et al. Assessment of suicidal intention: the Scale for Suicide Ideation. , 1979, Journal of consulting and clinical psychology.
[56] D. McManus,et al. Chronic administration of the antidepressants phenelzine, despiramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain , 1995, Cellular and Molecular Neurobiology.
[57] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[58] M. Palkovits,et al. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.
[59] Bernard R. Rosner,et al. Fundamentals of Biostatistics. , 1992 .
[60] P. Fox,et al. Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.
[61] A. Weissman. The Dysfunctional Attitude Scale: A Validation Study , 1979 .
[62] D. Kupfer,et al. Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.
[63] Paul J. Harrison,et al. β-blocker Binding to Human 5-HT1A Receptors in vivo and in vitro: Implications for Antidepressant Therapy , 2000, Neuropsychopharmacology.
[64] J. Mann,et al. INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS , 1983, The Lancet.
[65] C. Bánki,et al. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms. , 1981, Journal of affective disorders.
[66] T. Cooper,et al. Hormone responses to fenfluramine and placebo challenge in endogenous depression , 1992, Psychiatry Research.
[67] I. Gotlib,et al. Factor structure of the dysfunctional attitude scale in a student population , 1986 .
[68] Marc Laruelle,et al. Methyl 3β‐(4‐[125I]Iodophenyl)Tropane‐2β‐Carboxylate In Vitro Binding to Dopamine and Serotonin Transporters Under “Physiological” Conditions , 1994 .